| View |
|
BR-966
|
Epoetin Alfa
|
Eporon
|
4,000IU/0.4mL
|
Solution For Injection (Iv/Sc)
|
Prescription Drug (RX)
|
0.4ml Solution in pre-filled glass syringe with 27G needle in plastic tray ( Box of 10's)
|
-
|
Dong-A ST Co., Ltd.
|
Korea
|
|
Caledan Pharma Corp.
|
Caledan Pharma Corp.
|
-
|
21 February 2020
|
22 August 2024
|
| View |
|
BR-968
|
Bevacizumab
|
Avastin
|
100mg/ 4mL (25 mg/mL)
|
Concentrate for Solution for IV Infusion
|
Prescription Drug (RX)
|
4 mL net content in 6 mL capacity Type I Colourless Glass Vial (Box of 1's)
|
-
|
F. Hoffman-La Roche Ltd.
|
Switzerland
|
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
31 August 2021
|
26 August 2024
|
| View |
|
BR-969
|
Bevacizumab
|
Avastin
|
400 mg/16 mL (25mg/mL)
|
Concentrate for Solution for
Infusion (IV)
|
Prescription Drug (RX)
|
Type I colourless glass vial x 16 mL (Box of 1's)
|
-
|
F. Hoffmann-La Roche, Ltd.
|
|
Switzerland
|
N/A
|
Roche (Philippines), Inc.
|
Initial (Variation)
|
24 March 2023
|
24 March 2028
|
| View |
|
BR-970
|
Varicella Zoster Virus Vaccine Live (Oka/Merck)
|
Zostavax
|
19400 PFU
|
Lyophilized Powder For Injection (Sc)
|
Prescription Drug (RX)
|
1 single dose glass vial containing lyophilized powder with butyl rubber stopper & aluminum flip off cap w/ 1 prefilled syringe containing the sterile diluent w/ chlorobutyl rubber plunger stopper & tip cap . Includes 2 unattached needles (25G & 23G)
|
-
|
Merck Sharp & Dohme Corp.
|
United States of America
|
|
Merck Sharp & Dohme (I.A.) Corporation
|
|
Initial
|
16 January 2020
|
28 August 2024
|
| View |
|
BR-972
|
Recombinant Human Erythropoietin
|
Espogen
|
4000 IU/ 0.4 mL
|
Solution For Injection
|
Prescription Drug (RX)
|
1 BOX X 6 PRE-FILLED SYRINGES
|
Hematopoietic Growth Factor
|
LG Life Sciences Ltd.
|
Korea
|
|
A-Z Market Enterprise Developers, Inc.
|
A-Z Market Enterprise Developers, Inc.
|
Automatic Renewal
|
21 September 2021
|
12 September 2026
|
| View |
|
BR-975
|
Human Chorionic Gonadotropin
|
PUBERGEN
|
5000 IU
|
Lyophilized Powder for Solution for Injection (IM)
|
Prescription Drug (RX)
|
1 LYOPHILIZED POWDER IN A 2mL USP TYPE 1 CLEAR GLASS VIAL + 1mL NaCl SOLUTION IN GLASS VIAL
|
Gonadotrophic Hormone
|
Sanzyme (P) Limited
|
India
|
|
BRADY PHARMA Inc.
|
BRADY PHARMA Inc.
|
Renewal
|
13 April 2022
|
11 April 2027
|
| View |
|
BR-977
|
Recombinant Human Insulin (70% Isophane/30% Soluble)
|
Humulin 70/30
|
100 IU/mL
|
Suspension for Injection (SC)
|
Prescription Drug (RX)
|
Type I clear and colorless glass vial (10 mL)
|
Intermediate-acting Insulin
|
Eli Lilly & Company
|
U.S.A.
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
17 March 2023
|
21 July 2028
|
| View |
|
BR-980
|
Insulin Human (rDNA)
|
Humulin R
|
100 IU/mL
|
Suspension for Injection (SC)
|
Prescription Drug (RX)
|
Clear colourless glass vial with yellow flip-off seal x
10 mL (Box of 1's)
|
-
|
Eli Lilly and Company
|
U.S.A.
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
-
|
18 January 2022
|
22 May 2026
|
| View |
|
BR-981
|
Epoetin Alfa
|
Renogen
|
10,000 IU/mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
USP Type I pre-filled glass syringe with needle x 1 mL (Box of 1's)
|
-
|
Intas Pharmaceuticals, Ltd.
|
India
|
|
UNILAB, Inc.
|
UNILAB, Inc.
|
Renewal (Revalidation)
|
10 October 2022
|
03 October 2024
|
| View |
BR-983_PI_01.pdf
|
BR-983
|
Ustekinumab
|
Stelara
|
90 mg/mL
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
Single dose. 1 mL Pre-filled glass syringe with a
fixed 27G, half-inch needle and needle cover (Box of 1's)
|
-
|
Cilag AG
|
Switzerland
|
N/A
|
Johnson & Johnson (Philippines), Inc.
|
Johnson & Johnson (Philippines), Inc.
|
-
|
09 February 2022
|
14 October 2024
|
| View |
|
BR-986
|
Menotrophin
|
Gynogen HP
|
75 IU
|
Lyophilized Powder for Solution for Injection
(IM/SC)
|
Prescription Drug (RX)
|
2 mL USP Type I clear glass vial with grey bromobutyl
rubber stopper and aluminum flip-off seal (menotrophin as drug product) + 2 mL (Net content: 1 mL) USP Type I clear glass ampoule (0.9% sodium chloride as diluent) (Box of l’s]
|
Gonadotropins
|
Sanzyme (P) Ltd.
|
India
|
|
MedEthix Inc.
|
MedEthix Inc.
|
Initial (from Monitored Release)
|
27 July 2022
|
11 April 2027
|
| View |
BR-987_PI_01.pdf
|
BR-987
|
Omalizumab
|
Xolair
|
150 mg (150 mg in 1.2 mL)
|
Lyophilized Powder for Injection (SC)
|
Prescription Drug (RX)
|
Type I colorless glass vial + 2 mL Type I colorless glass
ampoule (Water for Injection as diluent) (Box of l's)
|
-
|
Novartis Pharma Stein AG
|
Switzerland
|
|
Novartis Healthcare Philippines, Inc.
|
|
Renewal
|
05 August 2021
|
24 January 2026
|
| View |
BR-990_PI_01.pdf
|
BR-990
|
Insulin Lispro
|
Humalog Mix50 Kwikpen
|
100 Units/mL (3.5 mg/mL) Suspension for Injection (SC) (50% Insulin Lispro and 50% Insulin Lispro Protamine)
|
Suspension for Injection (SC)
|
Prescription Drug (RX)
|
3 mL Type I pre-filled clear glass pen [Kwikpen] sealed with red halobutyl plunger at the bottom of the cartridge + bilayer elastomeric disc seal [Product contact layer: grey halobutyl and non-product contact layer: red isoprene] at the top (Box of 5's)
|
-
|
Eli Lilly Italia S.p.A.
|
Italy
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Monitored Release (Variation)
|
28 October 2022
|
28 October 2027
|
| View |
|
BR-991
|
Urofollitropin
|
Endogen HP
|
75 IU
|
Lyophilized Powder for Solution for Injection
(IM/SC)
|
Prescription Drug (RX)
|
2 mL USP Type I clear glass vial with grey bromobutyl
rubber stopper and aluminum flip-off seal (urofollitropin as drug product) + 2 mL (Net content: 1 mL) USP Type I clear glass ampoule (0.9% sodium chloride as diluent) [Box of l’s]
|
Gonadotropins
|
Sanzyme (P) Ltd.
|
India
|
|
MedEthix Inc.
|
MedEthix Inc.
|
Initial (from Monitored Release)
|
27 July 2022
|
11 April 2027
|
| View |
|
BR-992
|
Menotrophin
|
Menopur
|
Formulation: After reconstitution, 1 mL contains highly purified Menotrophin (human menopausal gonadotrophin, HMG) corresponding to:
Follicle Stimulating Hormone (FSH) Luteinizing Hormone (LH)
75 IU 75 IU
|
Lyophilized Powder for Solution for Injection (IM/SC)
|
Prescription Drug (RX)
|
One box contains two trays. Each tray holds five 2mL
Type glass vial with a rubber stopper and blue cap + five 1 mL Type I glass ampoules with blue and red ring (0.9% Sodium Chloride Solution as diluent).
|
Gonadotrophins
|
Ferring GmbH
|
Germany
|
|
Metro Drug, Inc.
|
|
Renewal
|
14 October 2020
|
24 September 2028
|
| View |
|
BR-993
|
Insulin human (rDNA)
|
Mixtard 30
|
100 IU/mL (70% Isophane + 30% Soluble Insulin Human)
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
10 mL Type I Glass Vial closed with Bromobutyl/
Polyisoprene Rubber Stopper and a Protective Tamper proof Cap
|
-
|
Novo Nordisk A/S
|
Denmark
|
N/A
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
N/A
|
-
|
09 June 2021
|
11 November 2024
|
| View |
|
BR-995
|
Insulin Human (rDNA)
|
Insulyf-R (Regular)
|
100 IU/mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
USP Type I glass vial x 10 mL (Box of l’s)
|
Insulins and Analogues
|
Biocon Limited
|
India
|
|
UNILAB, Inc.
|
UNILAB, Inc.
|
Automatic Renewal
|
14 October 2021
|
05 November 2026
|
| View |
|
BR-996
|
Isophane Insulin
|
Insulyf-N (Nph)
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Prescription Drug (RX)
|
USP Type I glass vial x 10 mL (Box of l's)
|
Insulins and Analogues
|
Biocon Limited
|
India
|
|
UNILAB, Inc.
|
UNILAB, Inc.
|
Renewal
|
22 October 2021
|
05 November 2026
|
| View |
|
BR-997
|
Insulin Human (rDNA)
|
Insulyf-30/70 (Biphasic)
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Prescription Drug (RX)
|
USP Type I glass vial x 10 mL (Box of l's)
|
Insulins and Analogues
|
Biocon Limited
|
India
|
|
UNILAB, Inc.
|
UNILAB, Inc.
|
Automatic Renewal
|
01 October 2021
|
05 November 2026
|
| View |
BR-999_PI_01.pdf
|
BR-999
|
Insulin Degludec
|
Tresiba Flextouch
|
100 Units/mL
|
Solution For Injection (SC)
|
Prescription Drug (Rx)
|
Cartridge (Type I Glass) with a Plunger (Halobutyl)
and a Stopper (Halobutyl/Polyisoprene) contained in a Pre-filled Multidose Disposable Pen made of Polypropylene
|
-
|
Novo Nordisk A/S
|
Denmark
|
|
Novo Nordisk Pharmaceuticals (Phils.) Inc.
|
Novo Nordisk Pharmaceuticals (Phils.) Inc.
|
Initial
|
12 May 2021
|
16 December 2024
|